Stay updated with breaking news from Jacqueline Ameri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Takara Bio Europe has announced a licensing agreement with Denmark’s PanCryos, a pre-clinical stage biotech company, for its clinical-grade human embryonic stem (hES) cell lines, starting material for cell therapy development.
Search jobs 05-May-2021 Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes Göteberg, Sweden — May 05, 2021 — Life Science Newswire – Takara Bio Europe AB (TBEAB) and PanCryos are pleased to announce that they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucose-responsive beta cells and is one of several customers in TB...